


Vincent Sobanski
1.8K posts

@VSobanski
Prof. Internal medicine @UFR3S_ULille @CHU_Lille | AI & autoimmunity @LilleInfinite @Inserm @InstUnivFr | Vice-Dean Digital health & Communication




Anti-RNA polymerase III antibodies (ARA) prevalence and clinical associations in systemic sclerosis (SSc) ◦ The overall prevalence of ARA in SSc within the existing literature is 9%, but is variable. ◦ Meta-analysis confirmed associations of ARA with diffuse cutaneous subset (OR: 2.20), scleroderma renal crisis (OR: 7.82), and cancer (OR: 1.86). ◦ ARA's clinical phenotype also includes a higher risk of gastric antral vascular ectasia (OR: 2.70), heart involvement (OR: 1.93), joint manifestations (OR: 1.29), and interstitial lung disease (OR: 1.10). *Elhannani A et al. Anti-RNA polymerase III antibodies in systemic sclerosis: prevalence and clinical associations from a systematic review and meta-analysis. Rheumatology (Oxford), 2025. 🔗doi.org/10.1093/rheuma…












📣REACTIVE médecins, c'est parti ! Qui ? 🩺 médecins thésés 🤝 suivant des patient(e)s pour des maladies chroniques 🇫🇷 en France Où ? 👉 process.care/survey/reactiv… 💻 conseil : sur ordinateur > smartphone Quand ? 🤸♀️ dès maintenant ⏰ 5 min Ensuite ? ⏩faites passer ! 🎯n=1000






























